XR Vision™ SaaS +
Data Flywheel.
Dual Moat.
US-First.

Category creation: Sealed-Product Authentication.

1 // The Problem

Global supply chains have a blind spot inside the seal. Serialization and surface
markers verify only verify packaging, not what’s inside.

This blind spot fuels hundreds of billions in annual losses globally—from counterfeit infiltration and diversion to packaging-level verification failures across pharmaceuticals, medtech, and consumer goods.

Regulators are closing in: DSCSA (US 2024) and EU FMD / UDI mandates now require content-level traceability.

2 // Our Solution

XR Vision™ combines X-ray with radiologist-trained AI to verify sealed products instantly and non-destructively. It authenticates completeness, configuration, and integrity at line speed, logging every scan to a tamper-proof compliance record.

Key Differentiators:

1. RADIOLOGIST-TRAINED AI: Interprets internal geometry and material signatures

1.
RADIOLOGIST-TRAINED AI: Interprets internal geometry and material signatures

2. NO RIP/REPLACE: Works with existing scanners and systems

2.
NO RIP/REPLACE: Works with existing scanners and systems

3. DATA MOAT: Each scan compounds proprietary labeled image libraries

3.
DATA MOAT: Each scan compounds proprietary labeled image libraries

4. MARKER IP: Radiographic inks or additional security layer

4.
MARKER IP:
  Radiographic inks or additional security layer

3 // Market & Timing

TAM:

~$345B–$415B in global authentication, verification, and product-security spend across pharmaceuticals, medical devices, CPG, and luxury goods.

SAM:

~$25B–$35B in high-value, sealed products where content-level verification is required or strongly incentivized.

SOM:

~$360M–$680M in reachable ARR at <1% penetration across priority verticals over the next 4–5 years.

4 // Revenue Model

SaaS & Data Licensing: Recurring, compounding ARR as every scan grows dataset value.

1. Annual SaaS licenses per facility (platform + AI)

1.
Annual SaaS licenses per facility (platform + AI)

2. Per-scan data licensing to regulators, insurers, and risk-analytics networks

2.
Per-scan data licensing to regulators, insurers, and risk-analytics networks

5 // Investor ROI

1. < 12 months to paid pilots → proof of revenue

1.
< 12 months to paid pilots → proof of revenue

2. Sticky SaaS + data resale → scalable ARR

2.
Per-scan data licensing to regulators, insurers, and risk-analytics networks

3. $1 B+ exit value potential

3.
$1 B+ exit value potential

XR Vision™ is the first platform turning sealed-package compliance into recurring data revenue.

Join the Future of Supply Chain Verification

Request our investor materials to explore partnerships, pilot opportunities, and current funding rounds

Coming soon //

Insights

Team

CONTACT US

Client login

Investors

XR Vision™ SaaS +
Data Flywheel.
Dual Moat.
US-First.

Category creation: Sealed-Product Authentication.

1 // The Problem

Global supply chains have a blind spot inside the seal. Serialization and surface
markers verify only verify packaging, not what’s inside.

This blind spot fuels hundreds of billions in annual losses globally—from counterfeit infiltration and diversion to packaging-level verification failures across pharmaceuticals, medtech, and consumer goods.

Regulators are closing in: DSCSA (US 2024) and EU FMD / UDI mandates now require content-level traceability.

2 // Our Solution

XR Vision™ combines X-ray with radiologist-trained AI to verify sealed products instantly and non-destructively. It authenticates completeness, configuration, and integrity at line speed, logging every scan to a tamper-proof compliance record.

Key Differentiators:

1. RADIOLOGIST-TRAINED AI: Interprets internal geometry and material signatures

1.
RADIOLOGIST-TRAINED AI: Interprets internal geometry and material signatures

2. NO RIP/REPLACE: Works with existing scanners and systems

2.
NO RIP/REPLACE: Works with existing scanners and systems

3. DATA MOAT: Each scan compounds proprietary labeled image libraries

3.
DATA MOAT: Each scan compounds proprietary labeled image libraries

4. MARKER IP: Radiographic inks or additional security layer

4.
MARKER IP:
  Radiographic inks or additional security layer

3 // Market & Timing

TAM:

~$345B–$415B in global authentication, verification, and product-security spend across pharmaceuticals, medical devices, CPG, and luxury goods.

SAM:

~$25B–$35B in high-value, sealed products where content-level verification is required or strongly incentivized.

SOM:

~$360M–$680M in reachable ARR at <1% penetration across priority verticals over the next 4–5 years.

4 // Revenue Model

SaaS & Data Licensing: Recurring, compounding ARR as every scan grows dataset value.

1. Annual SaaS licenses per facility (platform + AI)

1.
Annual SaaS licenses per facility (platform + AI)

2. Per-scan data licensing to regulators, insurers, and risk-analytics networks

2.
Per-scan data licensing to regulators, insurers, and risk-analytics networks

5 // Investor ROI

1. < 12 months to paid pilots → proof of revenue

1.
< 12 months to paid pilots → proof of revenue

2. Sticky SaaS + data resale → scalable ARR

2.
Per-scan data licensing to regulators, insurers, and risk-analytics networks

3. $1 B+ exit value potential

3.
$1 B+ exit value potential

XR Vision™ is the first platform turning sealed-package compliance into recurring data revenue.

Join the Future of Supply Chain Verification

Request our investor materials to explore partnerships, pilot opportunities, and current funding rounds